GeneDx Holdings Corp. (WGS)

SEC filing

GeneDx Holdings Corp.

WGS · CIK 1818331

4 · Jun 11, 2026 · Stueland Katherine sold 3,639 shares at $53.77/share ($195.7K); exercised options for 6,546 shares

Stueland Katherine sold 3,639 shares at $53.77/share ($195.7K); exercised options for 6,546 shares

xslF345X06/form4-06112026_080609.xml

xslF345X06/form4-06112026_080609.xmlSEC.gov

Graphics and non-inline formats (not embedded below).